使用附溶解测试和PBPK建模对口服剂型生物等价性前景预测的评论和综述
Kazuko Sagawa1, Priyanka Thipsay2
1Pharmaceutical Science, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut, 06340, USA. kazuko.sagawa@pfizer.com.
使用生理学基础药物动力学 (PBPK) 建模的虚拟生物等价 (VBE) 为临床试验提供了更快,更便宜,更道德的替代方案. 这种方法将体外溶解数据与药物动力学参数联系起来,以进行可靠的生物等价性评估.
科学领域:
- 药物动力学和药物开发
- 计算生物学
- 制药科学
背景情况:
- 临床生物等效 (BE) 试验是耗时的,昂贵的,并且在道德上具有挑战性.
- 基于生理学的药物动力学 (PBPK) 建模提供了一个有前途的替代方案.
- 虚拟生物等效 (VBE) 旨在减少对人类试验的依赖.
研究的目的:
- 审查综合溶解测试,PBPK建模和BE的历史发展和当前研究.
- 确定将这三种概念连接在一起的挑战和机遇.
- 提高药物产品性能和生物等效结果的预测.
主要方法:
- 使用PBPK建模将体外溶解数据转化为药物动力学参数.
- 通过虚拟评估评估生物等价性 (BE).
- 审查关于溶解,PBPK和BE的历史和当前研究.
主要成果:
- 使用PBPK建模的VBE可以显著减少试验时间,成本和道德问题.
- 这种方法尽量减少BE评估中的I型和II型错误的风险.
- 解散,PBPK和BE之间的明确联系对于VBE的成功至关重要.
结论:
- 了解溶解机制的进步可以改善PBPK模型的预测.
- 未来的PBPK建模应该整合这些进步以获得可靠的VBE.
- 加强综合解散和BE结果之间的相关性增加了对VBE评估的信心.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
18:57Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
